![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Fatality Sparks Swiss Recall of AMAG’s Anemia Drug
Fatality Sparks Swiss Recall of AMAG’s Anemia Drug
June 6, 2013
A patient death and safety reports of hypersensitivity reactions to AMAG Pharmaceuticals’ flagship iron deficiency drug Rienso has prompted a one-batch recall. The recall, specific to the Swiss market, was based on four reports of adverse events related to the ferumoxytol-based drug, according to an SEC filing.
Washington Drug Letter
Washington Drug Letter
Upcoming Events
-
21Oct